Microarray Solutions for Oncology Research

Trusted microarray analysis for uncompromised results

Chromosomal abnormalities and genomic instability are some of the most important aberrations in malignancies. Thermo Fisher Scientific offers advanced microarray solutions that are designed to provide comprehensive coverage and the highest resolution, so you do not miss important aberrations.

Optimize cancer sample profiling with a single assay that provides whole genome coverage to help advance oncology genetic research in your laboratory.

Learn more

neon-benefits-workflow

Customer & solutions overview

Raise your productivity to a whole new level

Hip Hip array! The new CytoScan Cytogenetics Suite with a two-day turnaround time, improved coverage, and automated interpretation and reporting capabilities is now available.

Learn more

Analyzing karyotypes in hematological malignancies are critical

Added precision to molecular karyotyping analysis is fast becoming the standard for detecting chromosomal aberrations in leukemias.

Read whitepaper

Application of CMA in oncology

Dr. Sukhanova demonstrates how combining chromosomal microarray analysis (CMA) with next-generation sequencing (NGS) assays helps to identify genetic aberrations in different types of cancer.

Attend webinar

Simplify hematological malignancy profiling

Learn how the combined power of just two platforms, whole genome microarrays and targeted NGS, is delivering faster answers and streamlined solutions in oncology.

View brochure

CytoScan HD Suite: Comprehensive cytogenetic analysis

High-resolution microarrays can assist in the understanding and characterization of biomarkers in hematological malignancies.

View flyer

Copy number analysis of FFPE samples with OncoScan assays

The OncoScan assays enable accurate analysis of copy number changes and allelic imbalances across the entire genome. These assays have been shown to perform well with highly degraded DNA, such as that derived from FFPE tumor samples.

Learn more